ionsys
incline therapeutics europe ltd - fentanüülvesinikkloriid - valu, postoperatiivne - valuvaigistid - täiskasvanud patsientidel on ionsys näidustatud ägeda mõõduka kuni raske postoperatiivse valu raviks.
fercelan kõvakapsel
g.l. pharma gmbh - raud(ii)fumaraat+foolhape+askorbiinhape - kõvakapsel - 202,8mg+0,8mg+100mg 100tk; 202,8mg+0,8mg+100mg 30tk; 202,8mg+0,8mg+100mg 56tk; 202,8mg+0,8mg+100mg 84tk; 202,8mg+0,8mg+100mg 28tk; 202,8mg+0,8mg+100mg 98tk; 202,8mg+0,8mg+100mg 20tk; 202,8mg+0,8mg+100mg 60tk
bittneri palsam suukaudne lahus
richard bittner ag - taimsed preparaadid - suukaudne lahus - 500ml 1tk; 100ml 1tk; 250ml 1tk; 50ml 1tk
purethal grasses+birch süstesuspensioon
hal allergy b.v. - puude ja heintaimede õietolm - süstesuspensioon - 20000aum 1ml 1tk
purethal birch süstesuspensioon
hal allergy b.v. - puude õietolm - süstesuspensioon - 20000aum 1ml 1tk
purethal grasses+trees süstesuspensioon
hal allergy b.v. - puude ja heintaimede õietolm - süstesuspensioon - 20000aum 1ml 1tk
traumeel s tablett
biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 250tk; 50tk
helituspan siirup
sopharma ad - luuderohuleht - siirup - 7mg 1ml 120ml 1tk
cystipret kaetud tablett
bionorica se - maasapiürt+leeskputkejuur+rosmariinileht - kaetud tablett - 36mg+36mg+36mg 60tk
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.